CDNS vs LAB · P/E 82, rev $5.30B vs rev $174.4M
Cadence Design Systems Inc (CDNS) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CDNS currently screens at market cap $88.27B and trailing P/E 82.0. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CDNS and LAB stock pages for the full models.
Not investment advice.